(AGENPARL) - Roma, 11 Novembre 2022 - (AGENPARL) – ven 11 novembre 2022 10 November 2022
For immediate release
REACTION: Investigation reveals big pharma’s lobbying against COVID-19 intellectual property waiver
An investigation by [Politico](http://tracking.vuelio.co.uk/tracking/click?d=Gz2tbWuDTj78DgqpfeWDejqs5EadnA3rL3OiyA4rm09TZ-GaGZpkzp7WwVjbRkwE2zorGXzIuyWPPmTmioa7dB5f5E9MHM-My9f7lCQlJ1s2SNwZGEpzEjgVqaNMeUx5CB6aX8e4_Dp08BGjTbv3B_dqQE1Jhs3sGaB_JJTQZd-0r7sAJQUj7IgTF8P-ds24U5KLGV-yzO4IbuX7JxhhqXM1) and [The Bureau of Investigative Journalism](http://tracking.vuelio.co.uk/tracking/click?d=6STqbI0j3hQuAQYoKbuChqlTMjUrUGXY7xQ4wyE5e9VYT8zdrQjke9l6z660P6rX0qUoV9faHTlH9nbnulTbOR7WoGXexX5I4gP98LRtmcmOgnYoGTjb3BKhBVmndYlAhSSROzQ6Z2i-z8V1AFniiR3bfFnpq3bT-nKesIghfVJHKfdxcC8ukuNC5sbXZefWoU6Z0ktsdxIjN_Xmmeh0bB81) has revealed that:
– Pharmaceutical companies threatened to withdraw investment from countries including Indonesia, Colombia and Belgium if they supported an intellectual property waiver for COVID-19 vaccines, tests, and treatments. Colombian officials in Geneva were told by their government that supporting the waiver might disrupt vaccine negotiations with Pfizer and others.
– Top pharmaceutical industry executives enjoyed direct access to senior officials within the EU, which was opposed to a waiver, and encouraged potentially rogue member countries, including Italy and France, to fall into line.
– The German government pressured fellow EU governments to oppose the TRIPS waiver, and when concerns were raised about how the EU waiver opposition looked to the rest of the world, Germany proposed that this could be managed with “smart communication on the topic” that “underlines the proactive role of the EU in providing vaccines globally.”
– When it became clear to the US business lobby that they could not affect the US position in support of an intellectual property waiver, the industry looked to Europe and the UK, which they saw as more receptive. As negotiations ramped up, the US Chamber of Commerce and US pharmaceutical lobbyists including the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) met the European Commission to lobby against the waiver. The UK’s biotech lobby met with George Freeman, a science minister, “to discuss intellectual property and the life sciences sector.”
– Between January 2020 and September 2022, 13 pharmaceutical lobby groups and companies held nearly 100 meetings with the most senior European Commission officials. In the U.K., there were more than 360 meetings between January 2020 and March 2022 — equivalent to nearly one every two days. Boris Johnson personally attended 11 of them.
– In the EU during 2021, COVID vaccine and treatment developers including Pfizer and Moderna and the largest pharma lobbying groups, including the EFPIA, spent at least €15 million on lobbying. The year before, the companies spent more than €15.7 million. In 2019, their lobbying costs were €13.9 million, according to data analyzed from LobbyFacts.
– Major industry players also paid at least 31 private consultancies to lobby the Commission on their behalf. AstraZeneca and Johnson & Johnson each paid around €700,000 in 2021 for consultancies working on topics such as the EU vaccines policy and the bloc’s strategy for COVID-19.
Responding, Max Lawson, Co-Chair of the People’s Vaccine Alliance and Head of Inequality Policy at Oxfam, said:
“These shocking allegations are a testament to the huge unaccountable power of big business in global politics. Pharmaceutical companies were seemingly granted unfettered access to the European Commission and the British and German governments, while countries that supported measures to improve vaccine access faced threats from the industry. When US lobbyists couldn’t influence the US government, they turned to the EU and UK. This is not how life and death decisions should be made.
“Millions died without access to vaccines while pharmaceutical companies gouged extraordinary profits from the pandemic. Rich countries expressed warm words and pledged donations, but to Germany, the UK, Switzerland, and the European Commission, it was apparently just a PR exercise. In the end, global solidarity was snuffed out by the wealthy pharmaceutical lobby, which is not how a healthy democracy should function.
“There is, however, a glimmer of hope amid these revelations. The narrow outcome of TRIPS negotiations set an important precedent, recognising that intellectual property rules are a barrier to accessing medical tools. World Trade Organization members are now deciding whether to extend the decision to cover tests and treatments. That could ensure that everyone, everywhere has access to lifesaving medical tools that reduce COVID-19 hospitalisations and death. While big pharma will once again use all of its lobbying might to protect its medical monopolies, governments must ensure this time that they put people’s lives before profits.
/Ends
Notes to editors
– This is a reaction to revelations in an investigation by Ashleigh Furlong, Sarah Anne Aarup of Politico and Samuel Horti of The Bureau of Investigative Journalism.
– Politico, Who killed the COVID vaccine waiver?: [https://www.politico.eu/article/covid-vaccine-poor-countries-waiver-killed/](http://tracking.vuelio.co.uk/tracking/click?d=Gz2tbWuDTj78DgqpfeWDejqs5EadnA3rL3OiyA4rm09TZ-GaGZpkzp7WwVjbRkwE2zorGXzIuyWPPmTmioa7dB5f5E9MHM-My9f7lCQlJ1s2SNwZGEpzEjgVqaNMeUx59oepI7pDvWJiwyJlPZCEUBL_spUtlSnWWk_RBo7jqEn_YR_gF1h1_iMiNLvWxbipvsBg0OkXaMaYMIPgXIoihgI1)
– The Bureau of Investigative Journalism, Who killed the vaccine waiver?: [https://www.thebureauinvestigates.com/stories/2022-11-10/who-killed-the-vaccine-waiver](http://tracking.vuelio.co.uk/tracking/click?d=6STqbI0j3hQuAQYoKbuChqlTMjUrUGXY7xQ4wyE5e9VYT8zdrQjke9l6z660P6rX0qUoV9faHTlH9nbnulTbOR7WoGXexX5I4gP98LRtmcmOgnYoGTjb3BKhBVmndYlAhSSROzQ6Z2i-z8V1AFniidLyqQhXcn1clvJuvztW_swWX8HOepNeSfwqJaN73UgAtpWYSGpU2_de24eYT99KAgFskAyglIo1Fa3kn_wmdvXa0)
Media contact
Joe Karp-Sawey, Senior Media Advisor, People’s Vaccine Alliance
[Unsubscribe](http://tracking.vuelio.co.uk/tracking/unsubscribe?d=fj2oyEdWUr7lBWS49Q8LmZ7lFZZhodPDdq7HoIt8u3b7BwO8jghbdhMjczQXD5JzBxVfxFk25VWp44VHSSUZgmiSJe8VpMtWYr6nKWmdp-EO0)
People’s Vaccine Alliance (part of Frontline Aids), 91 Davigdor Road, Hove, BN3 1RE, United Kingdom
Trending
- Fondazione Oristano – Assegnati i premi nazionali per le migliori tesi sul patrimonio culturale del territorio
- Sicurezza, Durigon: approvata Strade Sicure, impegno Lega vince
- Parità di genere come opportunità per le imprese: focus su certificazione e trasparenza retributiva
- Agenzia nr. 1558 – IV Commissione, sanzioni per i flussi turistici: allo studio una possibile modifica della legge regionale per ridurre gli importi
- NUOVI LEA, CAVANDOLI (LEGA): “PIÙ PREVENZIONE E DIAGNOSI PRECOCE PER TUTTI I TERRITORI
- Sicurezza stradale, il Consiglio comunale approva l’estensione della convenzione con la Città metropolitana a tutto il territori
- Salone Nautico, deputati Pd, “aspettiamo da Palazzo Chigi spiegazioni dovute su esclusione Salis dal palco
- L. ELETTORALE, GENTILE (FI): “RIFORMA GARANTISCE STABILITÀ E LIBERTÀ DI VOTO. STOP A GIOCHI DI PALAZZO
- Cannabis: assolto il Segretario di Radicali Italiani
- Governo: Nevi, ha restituito oltre 100 miliardi con meno tasse, ora serve più Europa sull’energia